Douglas R. Galasko, MD
Affiliations: | Neuroscience | University of California, San Diego, La Jolla, CA |
Area:
DementiaWebsite:
http://neurograd.ucsd.edu/faculty/detail.php?id=30Google:
"Douglas Galasko"Bio:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=73
http://ucsd.photobooks.com/directory/profile.asp?setsize=10000&dbase=main&pict_id=0001460
Mean distance: 19.84 (cluster 32)
Cross-listing: Alzheimer's Tree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Thomas KR, Bangen KJ, Edmonds EC, et al. (2021) Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease-related declines. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12238 |
| Gate D, Tapp E, Leventhal O, et al. (2021) CD4 T cells contribute to neurodegeneration in Lewy body dementia. Science (New York, N.Y.). eabf7266 |
| Edmonds EC, Smirnov DS, Thomas KR, et al. (2021) Data-Driven vs Consensus Diagnosis of MCI: Enhanced Sensitivity for Detection of Clinical, Biomarker, and Neuropathologic Outcomes. Neurology |
| Salloway S, Farlow M, McDade E, et al. (2021) A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nature Medicine |
| Bangen KJ, Thomas KR, Weigand AJ, et al. (2021) Elevated plasma neurofilament light predicts a faster rate of cognitive decline over 5 years in participants with objectively-defined subtle cognitive decline and MCI. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Barker MS, Manoochehri M, Rizer SJ, et al. (2021) Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 139: 99-115 |
| Caldwell AB, Liu Q, Schroth GP, et al. (2020) Dedifferentiation and neuronal repression define familial Alzheimer's disease. Science Advances. 6 |
| Marshall GA, Sikkes SAM, Amariglio RE, et al. (2020) Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12118 |
| Sandau US, Wiedrick JT, Smith SJ, et al. (2020) Performance of Validated MicroRNA Biomarkers for Alzheimer's Disease in Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad |
| Weigand AJ, Bondi MW, Thomas KR, et al. (2020) Association of anticholinergic medication and AD biomarkers with incidence of MCI among cognitively normal older adults. Neurology |